MedTrace Logo

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

NCT02537691 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 483

Last updated 2019-04-09

No results posted yet for this study

Summary

Prospective, single-arm, longitudinal, international, multicenter study in a real-world cohort of adult severe asthma participants being conducted to assess the relationships between asthma biomarkers and asthma-related health-outcomes for a period of 52 weeks.

Conditions

Interventions

DRUG

FP

ICS consisting of FP will be administered by DPI (or equivalent) as per investigator discretion.

DRUG

LABA

LABA will be administered as per investigator discretion.

DRUG

LTRA

LTRA will be administered as per investigator discretion.

DRUG

LAMA

LAMA will be administered as per investigator discretion.

DRUG

Theophylline

Theophylline will be administered as per investigator discretion.

DRUG

Oral Corticosteroids

Oral corticosteroids will be administered as per investigator discretion.

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-28
Primary Completion
2017-07-10
Completion
2017-07-10

Countries

  • United States
  • Belgium
  • Bulgaria
  • Canada
  • Denmark
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Netherlands
  • Portugal
  • Russia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537691 on ClinicalTrials.gov